|
1
|
Wong SS, Kim KM, Ting JC, Yu K, Fu J, Liu
S, Cristescu R, Nebozhyn M, Gong L, Yue YG, et al: Genomic
landscape and genetic heterogeneity in gastric adenocarcinoma
revealed by whole-genome sequencing. Nat Commun. 5:54772014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kang G, Hwang WC, Do IG, Wang K, Kang SY,
Lee J, Park SH, Park JO, Kang WK, Jang J, et al: Exome sequencing
identifies early gastric carcinoma as an early stage of advanced
gastric cancer. PLoS One. 8:e827702013. View Article : Google Scholar :
|
|
3
|
Hu B, El Hajj N, Sittler S, Lammert N,
Barnes R and Meloni-Ehrig A: Gastric cancer: Classification,
histology and application of molecular pathology. J Gastrointest
Oncol. 3:251–261. 2012.PubMed/NCBI
|
|
4
|
Zang ZJ, Cutcutache I, Poon SL, Zhang SL,
McPherson JR, Tao J, Rajasegaran V, Heng HL, Deng N, Gan A, et al:
Exome sequencing of gastric adenocarcinoma identifies recurrent
somatic mutations in cell adhesion and chromatin remodeling genes.
Nat Genet. 44:570–574. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bass AJ, Thorsson V, Shmulevich I,
Reynolds SM, Miller M, Bernard B, Hinoue T, Laird PW, Curtis C,
Shen H, et al Cancer Genome Atlas Research Network: Comprehensive
molecular characterization of gastric adenocarcinoma. Nature.
513:202–209. 2014. View Article : Google Scholar :
|
|
6
|
Ding Y, Yang Q, Wang B, Ye G and Tong X:
The correlation of MGMT promoter methylation and
clinicopathological features in gastric cancer: A systematic review
and meta-analysis. PLoS One. 11:e01655092016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baroudi O and Benammar-Elgaaied A:
Involvement of genetic factors and lifestyle on the occurrence of
colorectal and gastric cancer. Crit Rev Oncol Hematol. 107:72–81.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou J, Shen J, Seifer BJ, Jiang S, Wang
J, Xiong H, Xie L, Wang L and Sui X: Approaches and genetic
determinants in predicting response to neoadjuvant chemotherapy in
locally advanced gastric cancer. Oncotarget. 8:30477–30494.
2017.
|
|
9
|
Qi J, Zhang P, Wang Y, Chen H and Li Y:
Does total gastrectomy provide better outcomes than distal subtotal
gastrectomy for distal gastric cancer? A systematic review and
meta-analysis. PLoS One. 11:e01651792016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lasserre C, Christa L, Simon MT, Vernier P
and Bréchot C: A novel gene (HIP) activated in human primary liver
cancer. Cancer Res. 52:5089–5095. 1992.PubMed/NCBI
|
|
11
|
Dusetti NJ, Frigerio JM, Fox MF, Swallow
DM, Dagorn JC and Iovanna JL: Molecular cloning, genomic
organization, and chromosomal localization of the human
pancreatitis-associated protein (PAP) gene. Genomics. 19:108–114.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Christa L, Carnot F, Simon MT, Levavasseur
F, Stinnakre MG, Lasserre C, Thepot D, Clement B, Devinoy E and
Brechot C: HIP/PAP is an adhesive protein expressed in
hepatocarcinoma, normal Paneth, and pancreatic cells. Am J Physiol.
271:G993–G1002. 1996.PubMed/NCBI
|
|
13
|
Liu JL, Cui W, Li B and Lu Y: Possible
roles of reg family proteins in pancreatic islet cell growth.
Endocr Metab Immune Disord Drug Targets. 8:1–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L, Bachem MG, Zhou S, Sun Z, Chen J,
Siech M, Bimmler D and Graf R: Pancreatitis-associated protein
inhibits human pancreatic stellate cell MMP-1 and -2, TIMP-1 and -2
secretion and RECK expression. Pancreatology. 9:99–110. 2009.
View Article : Google Scholar
|
|
15
|
Lieu HT, Batteux F, Simon MT, Cortes A,
Nicco C, Zavala F, Pauloin A, Tralhao JG, Soubrane O, Weill B, et
al: HIP/PAP accelerates liver regeneration and protects against
acetaminophen injury in mice. Hepatology. 42:618–626. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Choi B, Suh Y, Kim WH, Christa L, Park J
and Bae CD: Downregulation of regenerating islet-derived 3 alpha
(REG3A) in primary human gastric adenocarcinomas. Exp Mol Med.
39:796–804. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu Q, Fu R, Yin G, Liu X, Liu Y and Xiang
M: Microarray-based gene expression profiling reveals genes and
pathways involved in the oncogenic function of REG3A on pancreatic
cancer cells. Gene. 578:263–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu X, Wang J, Wang H, Yin G, Liu Y, Lei X
and Xiang M: REG3A accelerates pancreatic cancer cell growth under
IL-6-associated inflammatory condition: Involvement of a
REG3A-JAK2/STAT3 positive feedback loop. Cancer Lett. 362:45–60.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Zhou H, Han Y, Liu X, Wang M, Wang
X, Yin G, Li X and Xiang M: SOCS3 methylation in synergy with Reg3A
overexpression promotes cell growth in pancreatic cancer. J Mol Med
(Berl). 92:1257–1269. 2014. View Article : Google Scholar
|
|
20
|
Ye Y, Xiao L, Wang SJ, Yue W, Yin QS, Sun
MY, Xia W, Shao ZY and Zhang H: Up-regulation of REG3A in
colorectal cancer cells confers proliferation and correlates with
colorectal cancer risk. Oncotarget. 7:3921–3933. 2016. View Article : Google Scholar :
|
|
21
|
Lai Y, Li D, Li C, Muehleisen B, Radek KA,
Park HJ, Jiang Z, Li Z, Lei H, Quan Y, et al: The antimicrobial
protein REG3A regulates keratinocyte proliferation and
differentiation after skin injury. Immunity. 37:74–84. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kadowaki Y, Ishihara S, Miyaoka Y, Rumi
MA, Sato H, Kazumori H, Adachi K, Takasawa S, Okamoto H, Chiba T,
et al: Reg protein is overexpressed in gastric cancer cells, where
it activates a signal transduction pathway that converges on ERK1/2
to stimulate growth. FEBS Lett. 530:59–64. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han S, Khuri FR and Roman J: Fibronectin
stimulates non-small cell lung carcinoma cell growth through
activation of Akt/mammalian target of rapamycin/S6 kinase and
inactivation of lKB1/AMP-activated protein kinase signal pathways.
Cancer Res. 66:315–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han S, Sidell N and Roman J: Fibronectin
stimulates human lung carcinoma cell proliferation by suppressing
p21 gene expression via signals involving Erk and Rho kinase.
Cancer Lett. 219:71–81. 2005. View Article : Google Scholar : PubMed/NCBI
|
